Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus

NCT03986073 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: TQ-F3083 capsule 10 mg
DRUG: TQ-F3083 capsule 20 mg
DRUG: TQ-F3083 blank analog capsule
DRUG: TQ-F3083 blank analog capsule
DRUG: Linagliptin blank analog tablet
DRUG: Linagliptin tablet

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.